ENTRY       D12486            Mixture   Drug
NAME        Finasteride and tadalafil;
            Entadfi (TN)
PRODUCT     ENTADFI (Veru)
COMPONENT   Finasteride [DR:D00321], Tadalafil [DR:D02008]
CLASS       Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      ATC code: G04CB51
            Product: D12486<US>
EFFICACY    Prostatic hyperplasia treatment
COMMENT     Both finasteride and tadalafil are metabolized by CYP3A4.
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             G GENITO URINARY SYSTEM AND SEX HORMONES
              G04 UROLOGICALS
               G04C DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
                G04CB Testosterone-5-alpha reductase inhibitors
                 G04CB51 Finasteride and tadalafil
                  D12486  Finasteride and tadalafil &lt;US&gt;
            USP drug classification [BR:br08302]
             Genitourinary Agents
              Benign Prostatic Hypertrophy Agents
               Finasteride/ Tadalafil
                D12486  Finasteride and tadalafil
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D12486  Finasteride and tadalafil
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D12486
///
